Quarterly Metrics: Quick and Current Ratios for Rapport Therapeutics Inc (RAPP)

In the journey to outperform the market, investors delve into the art of stock selection. Choosing the right stocks can be a powerful driver for wealth accumulation.

3 Tiny Stocks Primed to Explode The world's greatest investor — Warren Buffett — has a simple formula for making big money in the markets. He buys up valuable assets when they are very cheap. For stock market investors that means buying up cheap small cap stocks like these with huge upside potential.

We've set up an alert service to help smart investors take full advantage of the small cap stocks primed for big returns.

Click here for full details and to join for free
Sponsored

As of close of business last night, Rapport Therapeutics Inc’s stock clocked out at $22.39, up 0.22% from its previous closing price of $22.34. In other words, the price has increased by $0.22 from its previous closing price. On the day, 53905.0 shares were traded. RAPP stock price reached its highest trading level at $23.95 during the session, while it also had its lowest trading level at $22.175.

Ratios:

To gain a deeper understanding of RAPP’s stock, we examine its different ratios. For the most recent quarter (mrq), Quick Ratio is recorded 45.91 and its Current Ratio is at 45.91. In the meantime, Its Debt-to-Equity ratio is 0.01 whereas as Long-Term Debt/Eq ratio is at 0.00.

On July 02, 2024, Stifel started tracking the stock assigning a Buy rating and target price of $35.

On July 02, 2024, Jefferies started tracking the stock assigning a Buy rating and target price of $35.Jefferies initiated its Buy rating on July 02, 2024, with a $35 target price.

Insider Transactions:

Investing in insider trades can also provide an investor with insight into how management views future stock prices. A recent insider transaction in this stock occurred on Jul 01 ’24 when HEALY JAMES bought 44,032 shares for $24.52 per share. The transaction valued at 1,079,575 led to the insider holds 40,851 shares of the business.

HEALY JAMES bought 558,824 shares of RAPP for $9,500,008 on Jun 10 ’24. The Director now owns 1,863,327 shares after completing the transaction at $17.00 per share.

Valuation Measures:

Investors should consider key stock statistics when deciding whether to invest or divest. In the wake of the recent closing price, RAPP now has a Market Capitalization of 818947840 and an Enterprise Value of 499936864.

Stock Price History:

Over the past 52 weeks, RAPP has reached a high of $29.74, while it has fallen to a 52-week low of $16.55. The 50-Day Moving Average of the stock is -2.84%, while the 200-Day Moving Average is calculated to be 0.00%.

Shares Statistics:

It appears that RAPP traded 147.81K shares on average per day over the past three months and 116720 shares per day over the past ten days. A total of 36.58M shares are outstanding, with a floating share count of 17.47M. Insiders hold about 52.23% of the company’s shares, while institutions hold 54.55% stake in the company. Shares short for RAPP as of 1731628800 were 1737758 with a Short Ratio of 11.76, compared to 1728950400 on 1918730. Therefore, it implies a Short% of Shares Outstanding of 1737758 and a Short% of Float of 5.17.

Most Popular